user

Bone scintigraphy screening in stage I-II breast cancer: Is it cost effective?

被引：0
|
作者：
Wikenheiser, KA [1 ]
Silberstein, EB [1 ]
机构：
[1] UNIV CINCINNATI, MED CTR, CINCINNATI, OH 45267 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 1996年 / 63卷 / 01期
关键词：
radionuclide imaging; breast neoplasms; bone neoplasms; cost-benefit analysis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
It is recommended that routine bone scans not be adopted for follow-up of patients with stage I-II breast cancer. Bone scintigraph should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.
引用
收藏
页码：43 / 47
页数：5
相关论文
共 50 条
  • [41] Digital Breast Tomosynthesis Screening for Breast Cancer: It Is Cost-effective!
    Slanetz, Priscilla J.
    RADIOLOGY, 2020, 297 (01) : 49 - 50
  • [42] Prognostic predictive value of Ki-67 in stage I-II triple-negative breast cancer
    Li, Fengyan
    Zhou, Xinhui
    Hu, Wendie
    Du, Yujie
    Sun, Jiayuan
    Wang, Yaxue
    FUTURE SCIENCE OA, 2023, 10 (01):
  • [43] WEEKLY 3D PHOTON CONCOMITANT BOOST IN ADJUVANT RADIOTHERAPY FOR STAGE I-II BREAST CANCER
    Giudici, S.
    Lucido, M. R.
    Bertocchi, M.
    Magglo, F.
    Orsatti, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S253 - S254
  • [44] An independent population-based validation of the adjuvant decision-aid for stage I-II breast cancer
    Olivotto, IA
    Bajdik, C
    Ravdin, PM
    Norris, B
    Coldman, AJ
    Speers, C
    Chia, S
    Gelmon, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 8S - 8S
  • [45] Acute reactions and cosmetic outcome after conservative surgery and adjuvant RT in stage I-II breast cancer
    Valli, MC
    Amadori, M
    Asnsghi, D
    Catalano, G
    Francolini, DC
    De Agostini, A
    Meregalli, S
    Molteni, M
    Palazzi, M
    Personeni, A
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S60 - S60
  • [46] FOLLOW-UP OF BREAST-CANCER PATIENTS STAGE I-II - A BASE-LINE STRATEGY
    HANNISDAL, E
    GUNDERSEN, S
    KVALOY, S
    LINDEGAARD, MW
    AAS, M
    FINNANGER, AM
    JORGENSEN, OG
    THEODORSEN, L
    HOST, H
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (07) : 992 - 997
  • [47] Is machine energy (4-8 MV) associated with outcome for stage I-II breast cancer patients?
    Monson, JM
    Chin, L
    Nixon, A
    Gage, I
    Silver, B
    Recht, A
    Harris, JR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (05): : 1095 - 1100
  • [48] CAPECITABINE AND GEMCITABINE IN METASTATIC BREAST CANCER: A PHASE I-II STUDY
    Giannessi, P. G.
    Di Marsico, R.
    Martella, F.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [49] Emotional "Patient-Oriented" Support in Young Patients With I-II Stage Breast Cancer: Pilot Study
    Di Giacomo, D.
    Ranieri, J.
    Donatucci, E.
    Perilli, E.
    Cannita, K.
    Passafiume, D.
    Ficorella, C.
    FRONTIERS IN PSYCHOLOGY, 2018, 9
  • [50] Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients
    Mandalà, M
    Moro, C
    Ferretti, G
    Calabro, MG
    Nolè, F
    Rocca, A
    Munzone, E
    Castro, A
    Curigliano, G
    ANTICANCER RESEARCH, 2001, 21 (1B) : 585 - 588
12345